Hikma Pharmaceuticals
HIK.L
$25.42
Share price
0.43%
Change (1 day)
18.79%
Change (1 year)
Categories
P/S ratio for Hikma Pharmaceuticals (HIK.L)
P/S ratio at the end of 2022: 1.62
According to Hikma Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.30713. At the end of 2022 the company had a P/S ratio of 1.62.
P/S ratio history for Hikma Pharmaceuticals from 2006 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 1.62 | -49.82% |
| 2021 | 3.24 | -13.54% |
| 2020 | 3.74 | 11.6% |
| 2019 | 3.36 | 19.05% |
| 2018 | 2.82 | 32.14% |
| 2017 | 2.13 | -35.88% |
| 2016 | 3.33 | -48.17% |
| 2015 | 6.42 | 21.76% |
| 2014 | 5.27 | 53.56% |
| 2013 | 3.43 | 28.51% |
| 2012 | 2.67 | 10.15% |
| 2011 | 2.42 | -35.58% |
| 2010 | 3.76 | 31.97% |
| 2009 | 2.85 | 73.09% |
| 2008 | 1.65 | -64.97% |
| 2007 | 4.70 | -13.94% |
| 2006 | 5.47 |